US Map / Washington D.C.
State DC

Clinical Trials in Washington D.C.

Washington D.C. is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Washington D.C. and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 114 actively recruiting studies with Washington D.C. sites out of 114 registered in total. The busiest research areas in Washington D.C. are Solid Tumor, Colorectal Cancer, Neuroblastoma. Leading sponsors running trials in the state include Children's National Research Institute, National Cancer Institute (NCI), Merck Sharp & Dohme LLC. By stage, Washington D.C. trials break down as Phase 1 (23), Phase 2 (30), Phase 3 (25), Phase 4 (2).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
114
Recruiting Now
114
← Back to US Map
Top Conditions in Washington D.C.
Solid Tumor (4)Colorectal Cancer (3)Neuroblastoma (3)Stroke (3)Crohn Disease (3)Diabetic Peripheral Neuropathic Pain (2)Prostate Cancer (2)Sarcoma (2)Sickle Cell Disease (2)Asthma (2)Large B-cell Lymphoma (2)Becker Muscular Dystrophy (2)

Frequently Asked Questions — Clinical Trials in Washington D.C.

How many clinical trials are currently recruiting in Washington D.C.?
ClinicalMetric currently tracks 114 actively recruiting clinical trials with at least one location in Washington D.C.. The total number of registered studies—including active but not currently enrolling trials—is 114. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Washington D.C.?
Washington D.C. hosts clinical trials across a broad range of medical conditions, including Solid Tumor, Colorectal Cancer, Neuroblastoma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Washington D.C. serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Washington D.C.?
To join a clinical trial in Washington D.C., browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Washington D.C. maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Washington D.C.

NCT06046079 N/A
Recruiting
Predictors of Health Service Utilizations Among Key Population in Washington DC
Condition
Pre-exposure Prophylaxis
Enrollment
100 pts
Location
United States
Sponsor
Us Helping Us, People Into Liv
View Trial →
NCT06988774 N/A
Recruiting
Assessment of Tubal Occlusion During Minimally Invasive Myomectomy
Condition
Fallopian Tube Patency Tests
Enrollment
50 pts
Location
United States
Sponsor
Medstar Health Research Instit
View Trial →
NCT05443126 Phase 1, Phase 2
Recruiting
A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancie...
Condition
NSCLC
Enrollment
265 pts
Location
United States, France, Germany
Sponsor
Ellipses Pharma
View Trial →
NCT05672615 N/A
Recruiting
Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated...
Condition
Non-Muscle Invasive Bladder Cancer
Enrollment
42 pts
Location
United States
Sponsor
Johns Hopkins University
View Trial →
NCT05141058 Phase 1
Recruiting
T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients
Condition
SARS-CoV-2 Infection
Enrollment
24 pts
Location
United States
Sponsor
Children's National Research I
View Trial →
NCT07086976 Phase 3
Recruiting
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzab...
Condition
Autoimmune Haemolytic Anaemia
Enrollment
90 pts
Location
United States, Argentina, Austria
Sponsor
Sanofi
View Trial →
NCT05701917 N/A
Recruiting
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombos...
Condition
Venous Thromboembolism
Enrollment
300 pts
Location
United States, Austria, Finland
Sponsor
Inari Medical
View Trial →
NCT07664176 Phase 1
Recruiting
NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed...
Condition
Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma
Enrollment
30 pts
Location
United States
Sponsor
Children's National Research I
View Trial →
NCT00009633 N/A
Recruiting
Follow-up Visit of High Risk Infants
Condition
Infant, Newborn
Enrollment
68,000 pts
Location
United States
Sponsor
NICHD Neonatal Research Networ
View Trial →
NCT06628908 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabet...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
1,100 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT07308808 EARLY_Phase 1
Recruiting
Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation
Condition
Spinal Cord Injuries (SCI)
Enrollment
40 pts
Location
United States
Sponsor
Medstar Health Research Instit
View Trial →
NCT06551116 N/A
Recruiting
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 i...
Condition
HER2-positive Metastatic Breast Cancer
Enrollment
200 pts
Location
United States
Sponsor
Abramson Cancer Center at Penn
View Trial →
NCT04649242 Phase 3
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Condition
Pediatric Migraine
Enrollment
2,100 pts
Location
United States, Canada, China
Sponsor
Pfizer
View Trial →
NCT07337642 N/A
Recruiting
Comparing Collared and Collarless Femoral Stems in Primary Total Hip Arthroplast...
Condition
Primary Total Hip Arthroplasty
Enrollment
100 pts
Location
United States
Sponsor
Medstar Health Research Instit
View Trial →
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07144150 N/A
Recruiting
EVERO Drug-coated Balloon (DCB) Randomized Trial
Condition
Peripheral Vascular Disease
Enrollment
410 pts
Location
United States
Sponsor
Cook Research Incorporated
View Trial →
NCT06814717 Phase 2
Recruiting
A Safety, Tolerability and Pharmacokinetic Study of cP12 in Adults With Up To 10...
Condition
Thermal Burns
Enrollment
6 pts
Location
United States
Sponsor
Neomatrix Therapeutics, Inc.
View Trial →
NCT06512350 N/A
Recruiting
Identifying Patterns in the Breath of Individuals With Breast Cancer
Condition
Breast Cancer
Enrollment
5,175 pts
Location
United States, Canada
Sponsor
Breathe BioMedical Inc
View Trial →
NCT06608823 N/A
Recruiting
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
Condition
Aortic Regurgitation
Enrollment
1,016 pts
Location
United States
Sponsor
JenaValve Technology, Inc.
View Trial →
NCT06941025 N/A
Recruiting
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Ass...
Condition
Fabry Disease
Enrollment
10 pts
Location
United States, Germany, Italy
Sponsor
Chiesi Farmaceutici S.p.A.
View Trial →
NCT05382559 Phase 1
Recruiting
A Study of ASP3082 in Adults With Advanced Solid Tumors
Condition
Solid Tumor
Enrollment
681 pts
Location
United States, China, France
Sponsor
Astellas Pharma Inc
View Trial →
NCT05878717 Phase 2, Phase 3
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosi...
Condition
Systemic Sclerosis Associated Interstitial Lung Disease
Enrollment
300 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
View Trial →
NCT06266455 N/A
Recruiting
Individualized Nutrition to Optimize Preterm Infant Growth and Neurodevelopment
Condition
Very Preterm Maturity of Infant
Enrollment
150 pts
Location
United States
Sponsor
Children's National Research I
View Trial →
NCT05973838 N/A
Recruiting
Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
Condition
Polysubstance Addiction
Enrollment
160 pts
Location
United States
Sponsor
University of Maryland, Colleg
View Trial →
NCT05743283 N/A
Recruiting
Efficacy of SynEx Wound Rinse in Civilian Surrogates of Combat Injury Wounds
Condition
Wound Heal
Enrollment
100 pts
Location
United States
Sponsor
Synedgen, Inc.
View Trial →
Page 2 of 5 — 114 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology